Global Sinusitis Treatment Market

Product Overview

Global Sinusitis Treatment Market size was USD 3.06 billion in 2021 and projected to grow from USD 3.3 billion in 2023 to USD 4.7 billion by 2032, exhibiting a CAGR of 4% during the forecast period.

Sinusitis is caused due to the blockage of nasal cavity by accumulation of fluid due to the presence of various germs like virus and bacteria. The tissue lining sinuses are air-filled pockets which get swollen in case of sinusitis and it may be either acute or chronic and can result in advancing to complications like meningitis and brain abscess if not treated. Sinusitis can be diagnosed with various ciliary function tests, blood tests, sinus CT scans, nasal cytology & allergy testing etc., and the treatment involves decongestants to surgery based on the severity. 

Market Highlights

Global Sinusitis Treatment Market is expected to project a CAGR of 4% during the forecast period, 2022-2032

Global Sinusitis Treatment Market is expected to reach USD 4.7 billion, growing at a CAGR of 4% during forecast period owing to the increasing sinusitis due to the pollution, growing demand for diagnostic tests and treatment, and growing advancements in technology related to sinusitis surgery which are all driving the demand for the growth of the Global Sinusitis Treatment Market. Increasing utilization of medical devices for diagnosis and treatment purpose and increasing treatment options using nasal corticosteroids, nasal sprays, decongestants etc. are boosting the growth of market.

Global Sinusitis Treatment Market Segmentation

Acute Sinusitis segment is expected to grow with high CAGR during the forecast period

Global Sinusitis Treatment Market is classified based on the Disease into Acute Sinusitis, Sub-acute Sinusitis, and Chronic Sinusitis. Acute sinusitis segment dominated the market in 2021 and is expected to continue its dominance over the forecast period. Acute sinusitis is usually caused due to the common cold and the symptoms in patients include nasal obstruction and congestion, which obstruct the sinuses by avoiding the flow of mucus. This increment in issues of common cold & flu increases the incidence of acute sinusitis and is anticipated to drive the demand for the growth of the global sinusitis treatment market in the forecast period.

Oral segment is expected to grow with high CAGR during the forecast period

Global Sinusitis Treatment Market is classified based on the Route of Administration into Injectable, Nasal, Topical, Oral. Oral segment dominated the market in 2021 and is expected to continue its dominance over the forecast period owing to the presence of several benefits of oral administration even the sustained & controlled delivery system, ease of administration, easy to formulate solid dosage forms, patient compliance, which are expected to boost the growth of the oral segment in Global Sinusitis Treatment Market during the forecast period.

Market Dynamics  

Growth Drivers

Growing Treatment Options is Expected to Boost the Growth of the Market

There are several treatment options available for sinusitis treatment like using Corticosteroids, Analgesics, Surgery Antibiotics, Antihistamines etc. Generally, antibiotics are prescribed for bacterial sinusitis involving the sphenoid, frontal, or ethmoid sinuses, due to the chances of facing severe problems related to sinusitis. Antibiotics like cephalosporins, Penicillins, and macrolides are prescribed for long durations which may boost the market growth. There is a requirement for better approach to treatment in adults with acute sinusitis. The expansion of several drug therapies and the increasing R&D efforts deliver new alternative solutions for sinusitis treatment.

Advancements in Technology is Expected to Boost the Growth of the Market

Several market opportunities are being created by the innovation of new treatment options and creating market expansion by development of new drug delivery techniques and drug combinations to treat sinusitis. These advancement in technologies by the key market players is resulting in the invention of new treatment option for various conditions. Growing educational programs and initiatives are aiming to improve awareness in patients regarding the necessity of treatment options for sinusitis management. Development of new advanced and innovative treatments procedures is anticipated to drive market growth.

Restraint

Adverse Effects by Drugs May Restrain the Growth of the Market

The treatment options for sinusitis involve antibiotics which cause several side effects like nausea, diarrhoea, vomiting, and abdominal pain which is anticipated to restrain the market growth. Nasal corticosteroids result in nosebleeds, headaches or dryness of nasal passages which may also hamper market growth.

Recent Developments

• In July 2022, Optinose declared the results of pre-planned analyses from the ReOpen trial program assessing XHANCE for treating patients with chronic sinusitis.
• In August 2021 Food and Drug Administration approved GlaxoSmithKline’s Nucala (mepolizumab), used for treating Chronic Rhinosinusitis with nasal polyps.

Global Sinusitis Treatment Market

Key Players Covered:

• Bayer AG
• Sanofi
• Pfizer Inc.
• OptiNose US, Inc.
• GSK plc.
• Regeneron Pharmaceuticals Inc
• Novartis AG
• Teva Pharmaceutical Industries
• Sanofi
• Mylan N.V
• Fresenius Kabi USA
• Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)

Regional Analysis

Global Sinusitis Treatment Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America dominated the sinusitis treatment market in 2021 owing to the growing prevalence of sinusitis in countries of this region. Increasing awareness on health and the presence of key market players in this region is anticipated to boost the growth of the Sinusitis Treatment market. Clinical trials in this region is also anticipated to drive the market growth over the forecast period. 

Impact of Covid-19 on Global Sinusitis Treatment Market

The COVID-19 outbreak had resulted in the economic downfall. Several countries had imposed travel restrictions and lockdown measures to control the spread of virus. The increased focus on Covid-19 pandemic had resulted in patients getting off their sinusitis medications due to the fear of virus. The reduced demand for diagnosis and treatment have resulted in affecting the sinusitis treatments market. COVID-19 resulted in several hospitals and clinics on postponing the elective procedures like sinus operations. Covid-19 had a negative impact on the growth of the Global Sinusitis Treatment market.

Global Sinusitis Treatment Market is further segmented by region into:

• North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
• Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
• Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
• Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
• Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA.

Global Sinusitis Treatment Market Scope and Segments:

Frequently Asked Questions (FAQ):